UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases

Viruses, 2014-07, Vol.6 (7), p.2735-2761

2014

Link zum Volltext

Verfügbarkeit prüfen

Pathogenesis of Influenza A/H5N1 Virus Infection in Ferrets Differs between Intranasal and Intratracheal Routes of Inoculation

The American journal of pathology, 2011-07, Vol.179 (1), p.30-36

2011

Link zum Volltext

Verfügbarkeit prüfen

Human Cytotoxic T Lymphocytes Directed to Seasonal Influenza A Viruses Cross-React with the Newly Emerging H7N9 Virus

Journal of Virology, 2014-02, Vol.88 (3), p.1684-1693

2014

Link zum Volltext

Verfügbarkeit prüfen

The Multibasic Cleavage Site in H5N1 Virus Is Critical for Systemic Spread along the Olfactory and Hematogenous Routes in Ferrets

Journal of Virology, 2012-04, Vol.86 (7), p.3975-3984

2012

Link zum Volltext

Verfügbarkeit prüfen

Recombinant Soluble, Multimeric HA and NA Exhibit Distinctive Types of Protection against Pandemic Swine-Origin 2009 A(H1N1) Influenza Virus Infection in Ferrets

Journal of Virology, 2010-10, Vol.84 (19), p.10366-10374

2010

Link zum Volltext

Verfügbarkeit prüfen

Yearly influenza vaccinations: a double-edged sword?

The Lancet infectious diseases, 2009-12, Vol.9 (12), p.784-788

2009

Link zum Volltext

Verfügbarkeit prüfen

Evasion of influenza A viruses from innate and adaptive immune responses

Viruses, 2012-09, Vol.4 (9), p.1438-1476

2012

Link zum Volltext

Verfügbarkeit prüfen

Poxvirus vectors

Vaccine, 2013-09, Vol.31 (39), p.4217-4219

2013

Link zum Volltext

Verfügbarkeit prüfen

Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus

PloS one, 2009-05, Vol.4 (5), p.e5538-e5538

2009

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial

The Lancet infectious diseases, 2014-12, Vol.14 (12), p.1196-1207

2014

Link zum Volltext

Verfügbarkeit prüfen

Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells

Journal of general virology, 2011-10, Vol.92 (Pt 10), p.2339-2349

2011

Link zum Volltext

Verfügbarkeit prüfen

Market implementation of the MVA platform for pre-pandemic and pandemic influenza vaccines: A quantitative key opinion leader analysis

Vaccine, 2015-08, Vol.33 (35), p.4349-4358

2015

Link zum Volltext

Verfügbarkeit prüfen

Influenza virus CTL epitopes, remarkably conserved and remarkably variable

Vaccine, 2009-10, Vol.27 (45), p.6363-6365

2009

Link zum Volltext

Verfügbarkeit prüfen

Induction of influenza (H5N8) antibodies by modified vaccinia virus Ankara H5N1 vaccine

Emerging infectious diseases, 2015-06, Vol.21 (6), p.1086-1088

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Vaccination with Different Combinations of MF59-Adjuvanted and Nonadjuvanted Seasonal and Pandemic Influenza Vaccines against Pandemic H1N1 (2009) Influenza Virus Infection in Ferrets

Journal of Virology, 2011-03, Vol.85 (6), p.2851-2858

2011

Link zum Volltext

Verfügbarkeit prüfen

Annual influenza vaccination affects the development of heterosubtypic immunity

Vaccine, 2012-12, Vol.30 (51), p.7407-7410

2012

Link zum Volltext

Verfügbarkeit prüfen

Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial

The Journal of infectious diseases, 2018-07, Vol.218 (4), p.614-623

2018

Link zum Volltext

Verfügbarkeit prüfen

Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine

Vaccine, 2014-09, Vol.32 (43), p.5614-5623

2014

Link zum Volltext

Verfügbarkeit prüfen

Recombinant Modified Vaccinia Virus Ankara–Based Vaccine Induces Protective Immunity in Mice against Infection with Influenza Virus H5N1

The Journal of infectious diseases, 2007-06, Vol.195 (11), p.1598-1606

2007

Link zum Volltext

Verfügbarkeit prüfen

Heterosubtypic immunity to H7N9 influenza virus in isogenic guinea pigs after infection with pandemic H1N1 virus

Vaccine, 2015-12, Vol.33 (49), p.6977-6982

2015

Link zum Volltext

Verfügbarkeit prüfen

Virus replication kinetics and pathogenesis of infection with H7N9 influenza virus in isogenic guinea pigs upon intratracheal inoculation

Vaccine, 2015-12, Vol.33 (49), p.6983-6987

2015

Link zum Volltext

Verfügbarkeit prüfen

Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice

Journal of general virology, 2010-07, Vol.91 (Pt 7), p.1743-1753

2010

Link zum Volltext

Verfügbarkeit prüfen

Blockade of ErbB2 and PD-L1 using a bispecific antibody to improve targeted anti-ErbB2 therapy

Oncoimmunology, 2019-11, Vol.8 (11), p.e1648171-e1648171

2019

Link zum Volltext

Verfügbarkeit prüfen

Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses

Journal of general virology, 2013-03, Vol.94 (Pt 3), p.583-592

2013

Link zum Volltext

Verfügbarkeit prüfen

Infection of the Upper Respiratory Tract with Seasonal Influenza A(H3N2) Virus Induces Protective Immunity in Ferrets against Infection with A(H1N1)pdm09 Virus after Intranasal, but Not Intratracheal, Inoculation

Journal of Virology, 2013-04, Vol.87 (8), p.4293-4301

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(41)
Berichte
(1)

Sprache

Englisch
(42)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(33)
Life Sciences & Biomedicine
(31)
Animals
(23)
Humans
(19)
Immunology
(18)
Female
(17)
Virology
(15)
Influenza Vaccines - Immunology
(14)
Influenza Virus
(13)
Biological And Medical Sciences
(11)
Pandemics
(11)
Influenza
(10)
Microbiology
(10)
Infectious Diseases
(9)
Influenza A Virus
(9)
Medicine, Research & Experimental
(9)
Research & Experimental Medicine
(9)
Viruses
(9)
Fundamental And Applied Biological Sciences. Psychology
(8)
Influenza A Virus, H1n1 Subtype - Immunology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases

Pathogenesis of Influenza A/H5N1 Virus Infection in Ferrets Differs between Intranasal and Intratracheal Routes of Inoculation

Human Cytotoxic T Lymphocytes Directed to Seasonal Influenza A Viruses Cross-React with the Newly Emerging H7N9 Virus

The Multibasic Cleavage Site in H5N1 Virus Is Critical for Systemic Spread along the Olfactory and Hematogenous Routes in Ferrets

Recombinant Soluble, Multimeric HA and NA Exhibit Distinctive Types of Protection against Pandemic Swine-Origin 2009 A(H1N1) Influenza Virus Infection in Ferrets

Yearly influenza vaccinations: a double-edged sword?

Evasion of influenza A viruses from innate and adaptive immune responses

Poxvirus vectors

Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus

Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial

Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells

Market implementation of the MVA platform for pre-pandemic and pandemic influenza vaccines: A quantitative key opinion leader analysis

Influenza virus CTL epitopes, remarkably conserved and remarkably variable

Induction of influenza (H5N8) antibodies by modified vaccinia virus Ankara H5N1 vaccine

Efficacy of Vaccination with Different Combinations of MF59-Adjuvanted and Nonadjuvanted Seasonal and Pandemic Influenza Vaccines against Pandemic H1N1 (2009) Influenza Virus Infection in Ferrets

Annual influenza vaccination affects the development of heterosubtypic immunity

Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial

Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine

Recombinant Modified Vaccinia Virus Ankara–Based Vaccine Induces Protective Immunity in Mice against Infection with Influenza Virus H5N1

Heterosubtypic immunity to H7N9 influenza virus in isogenic guinea pigs after infection with pandemic H1N1 virus

Virus replication kinetics and pathogenesis of infection with H7N9 influenza virus in isogenic guinea pigs upon intratracheal inoculation

Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice

Blockade of ErbB2 and PD-L1 using a bispecific antibody to improve targeted anti-ErbB2 therapy

Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses

Infection of the Upper Respiratory Tract with Seasonal Influenza A(H3N2) Virus Induces Protective Immunity in Ferrets against Infection with A(H1N1)pdm09 Virus after Intranasal, but Not Intratracheal, Inoculation

Suchergebnisse filtern